The Department of Imaging at the Dana-Farber Cancer Institute (DFCI) is seeking an expert in radiochemistry to establish an independent research laboratory, with an appointment as a tenure-track Assistant Professor of Radiology at Harvard Medical School. A research focus on positron emission tomography (PET) imaging using novel tracers and targeting moieties is desirable. Of particular interest to the institution would be translational research that enhances the ability to visualize key cellular and subcellular markers that are important in the interaction of immunotherapeutic strategies against cancerous tissues.
A generous package of support and laboratory space will be provided for successful candidates to allow his/her research to thrive in a nurturing academic and clinical environment. DFCI offers competitive salaries and an outstanding personal and professional benefits package.
DFCI also offers outstanding, state-of-the-art facilities to conduct this research program, including, among others, the Molecular Cancer Imaging Facility (MCIF), housing a fully staffed preclinical cyclotron, and the Lurie Cancer Imaging Facility (LCIF), housing small animal imaging PET/CT and SPECT/CT imaging systems. The cyclotron at MCIF is currently being upgraded to a GMP facility. In addition, a clinical cyclotron is available at Brigham and Women’s Hospital.
Review of applications will begin immediately with submissions open until February 8, 2019. All application materials, including your CV, a letter describing qualifications, and contact information of at least 3 references should be submitted to "firstname.lastname@example.org" and cc'd to "email@example.com". Please paste "PET Radiochemist Faculty Search" in the subject line.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.
The successful candidate for this position should have a Ph.D in the area of chemistry/radiochemistry. Experience in labeling of antibodies and antibody fragments (minibodies, nanobodies) with PET radiotracers, as well as experience with PET imaging in animal models, or an interest in immunotherapy research is desirable. Excellent communication skills and team-building and collaborative efforts would be additional valuable strengths.
Additional Salary Information: A generous package of support and laboratory space will be provided for successful candidates to allow his/her research to thrive in a nurturing academic and clinical environment. DFCI offers competitive salaries and an outstanding personal and professional benefits package.
Internal Number: 0001419
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School, a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center, a federally designated comprehensive cancer center. Dana-Farber also maintains affiliations with several schools of nursing in the Boston area.
Providing advanced training in cancer treatment and research for an international faculty, the Institute conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School and the Partners Health Care System, including Brigham and Women's Hospital, Boston Children's Hospital, and Massachusetts General Hospital.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the generous support of numerous foundations and individuals who contribute to the Institute's individual research and clinic programs or to the Jimmy Fund, the principal charity of the Institute.